Dr. Michael Hart is a physician and the first medical doctor to open a “cannabis clinic” in London, Ontario, the ReadyToGo Clinic. Hart’s clinic also receives patients who seek ketamine therapy. We’re pleased to have Dr. Hart with us on The Dales Report to discuss psychedelics like ketamine and psilocybin, and their possible future in treating depression.
Here’s some highlights from the interview
– There’s a recent study lending legitimacy to medical practitioners who want to prescribe psychedelics for depression
– Peers in the industry eager to prescribe psychedelics for depression – and psylocibin is likely to be the first
– People are inquiring more about ketamine
We are a business news platform that provides the latest and best insight on the stories making headlines around the world. We give Institutional and retail investors an inside edge in the competitive world of investing and profile companies that are making waves in their ever-growing industries.
We are The Dales Report.
Check out our website:
Subscribe to our channel at
Connect with us on our social media handles: